国药现代
(600420)
| 流通市值：135.46亿 | | | 总市值：135.46亿 |
| 流通股本：13.41亿 | | | 总股本：13.41亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 6,920,393,170.38 | 4,877,673,521.93 | 2,606,778,071.34 | 10,937,525,114.43 |
| 营业收入 | 6,920,393,170.38 | 4,877,673,521.93 | 2,606,778,071.34 | 10,937,525,114.43 |
| 二、营业总成本 | 5,860,075,336.79 | 3,975,475,386.48 | 2,109,040,170.15 | 9,209,243,716.28 |
| 营业成本 | 4,616,387,318.32 | 3,120,035,803.48 | 1,639,786,034.72 | 6,645,214,332.76 |
| 税金及附加 | 70,315,957.43 | 50,814,542.59 | 25,434,133.06 | 131,545,473.11 |
| 销售费用 | 354,815,378.47 | 267,345,485.35 | 182,917,156.79 | 1,151,961,230.5 |
| 管理费用 | 526,067,125.61 | 341,351,783.38 | 170,297,645.51 | 793,272,889.94 |
| 研发费用 | 331,629,773.76 | 229,501,770.24 | 110,732,450.33 | 575,929,683.34 |
| 财务费用 | -39,140,216.8 | -33,573,998.56 | -20,127,250.26 | -88,679,893.37 |
| 其中:利息费用 | 4,161,997.52 | 2,843,148.12 | 1,406,133.14 | 36,887,575.36 |
| 其中:利息收入 | 36,651,645.15 | 26,453,564.76 | 14,281,492.31 | 86,969,890.14 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | 68,287,525.45 | 41,030,017.72 | 20,681,510.13 | 64,105,907.49 |
| 资产处置收益 | -741,783.88 | -65,422.93 | -451,811.48 | -31,310,025.43 |
| 资产减值损失(新) | -58,835,473.22 | -38,676,688.82 | -19,213,632.51 | -168,498,777.81 |
| 信用减值损失(新) | -16,983,348.29 | -20,813,687.55 | -11,497,455.74 | 2,355,979.98 |
| 其他收益 | 51,659,244 | 36,491,371.98 | 21,799,967.01 | 156,989,031.04 |
| 四、营业利润 | 1,103,703,997.65 | 920,163,725.85 | 509,056,478.6 | 1,751,923,513.42 |
| 加:营业外收入 | 29,951,908.93 | 12,356,357.26 | 6,258,395.12 | 15,259,934.4 |
| 减:营业外支出 | 18,166,847.34 | 7,593,129.06 | 4,268,114.13 | 94,129,610.68 |
| 五、利润总额 | 1,115,489,059.24 | 924,926,954.05 | 511,046,759.59 | 1,673,053,837.14 |
| 减:所得税费用 | 182,260,157.23 | 154,746,888.67 | 87,507,012.67 | 340,974,126.89 |
| 六、净利润 | 933,228,902.01 | 770,180,065.38 | 423,539,746.92 | 1,332,079,710.25 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 933,228,902.01 | 770,180,065.38 | 423,539,746.92 | 1,332,079,710.25 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 801,171,565.94 | 672,066,877.31 | 361,413,759.19 | 1,083,622,881.88 |
| 少数股东损益 | 132,057,336.07 | 98,113,188.07 | 62,125,987.73 | 248,456,828.37 |
| 扣除非经常损益后的净利润 | 739,392,587.5 | 637,110,045.15 | 346,267,746.25 | 1,043,284,677.64 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.6 | 0.5 | 0.27 | 0.81 |
| (二)稀释每股收益 | 0.6 | 0.5 | 0.27 | 0.81 |
| 八、其他综合收益 | -290,964.78 | -290,964.78 | - | 174,838.86 |
| 归属于母公司股东的其他综合收益 | -290,964.78 | -290,964.78 | - | 174,838.86 |
| 九、综合收益总额 | 932,937,937.23 | 769,889,100.6 | 423,539,746.92 | 1,332,254,549.11 |
| 归属于母公司股东的综合收益总额 | 800,880,601.16 | 671,775,912.53 | 361,413,759.19 | 1,083,797,720.74 |
| 归属于少数股东的综合收益总额 | 132,057,336.07 | 98,113,188.07 | 62,125,987.73 | 248,456,828.37 |
| 公告日期 | 2025-10-30 | 2025-08-30 | 2025-04-29 | 2025-03-28 |
| 审计意见(境内) | | | | 标准无保留意见 |